Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
New technologies for biomarker discovery in multiple sclerosis.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
Dalfampridine Improves Sensorimotor Function in Rats With Chronic Deficits After Middle Cerebral Artery Occlusion.
A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Microglia: Architects of the Developing Nervous System.
Alemtuzumab 3-year data show durable effect on MS disability
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Structural mechanism for statin inhibition of HMG-CoA reductase.
Fingolimod for multiple sclerosis: a review for the specialist nurse.
Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
White matter volume is decreased in the brain of patients with neuromyelitis optica.
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
MRI characteristics of familial and sporadic multiple sclerosis patients.
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.

Pages